https://www.avient.com/sites/default/files/2021-06/fl.datasheet-packingyarn.pdf
No freedom from any patents or other industrial or intellectual property rights is granted or to be inferred.
They also add important characteristics, such as
SWELLCOAT® water-blocking, water repellence, adhe-
sion, color, and wear and UV-resistance to these and
many other applications.
We believe that our ongoing
commitment to protect the environment, to remain at
the forefront of fiber and coating technology, and to
‘treat others as we want to be treated’ will continue to
drive the success of our customers, shareholders, and
employees.
https://www.avient.com/sites/default/files/2021-06/fl.datasheet-belthose-reinforcement.pdf
No freedom from any patents or other industrial or intellectual property rights is granted or to be inferred.
They also add important characteristics, such as
SWELLCOAT® water-blocking, water repellence, adhe-
sion, color, and wear and UV-resistance to these and
many other applications.
We believe that our ongoing
commitment to protect the environment, to remain at
the forefront of fiber and coating technology, and to
‘treat others as we want to be treated’ will continue to
drive the success of our customers, shareholders, and
employees.
https://www.avient.com/sites/default/files/2021-06/fl.datasheet-industrialfabricyarn.pdf
No freedom from any patents or other industrial or intellectual property rights is granted or to be inferred.
They also add important characteristics, such as
SWELLCOAT® water-blocking, water repellence, adhe-
sion, color, and wear and UV-resistance to these and
many other applications.
We believe that our ongoing
commitment to protect the environment, to remain at
the forefront of fiber and coating technology, and to
‘treat others as we want to be treated’ will continue to
drive the success of our customers, shareholders, and
employees.
https://www.avient.com/sites/default/files/2021-06/fl.datasheet-ripcords.pdf
No freedom from any patents or other industrial or intellectual property rights is granted or to be inferred.
They also add important characteristics, such as
SWELLCOAT® water-blocking, water repellence, adhe-
sion, color, and wear and UV-resistance to these and
many other applications.
We believe that our ongoing
commitment to protect the environment, to remain at
the forefront of fiber and coating technology, and to
‘treat others as we want to be treated’ will continue to
drive the success of our customers, shareholders, and
employees.
https://www.avient.com/sites/default/files/2021-06/fl.us-.datasheet-vectranr-lcp.pdf
No freedom from any patents or other industrial or intellectual property rights is granted or to be inferred.
They also add important characteristics, such as
SWELLCOAT® water-blocking, water repellence, adhe-
sion, color, and wear and UV-resistance to these and
many other applications.
We believe that our ongoing
commitment to protect the environment, to remain at
the forefront of fiber and coating technology, and to
‘treat others as we want to be treated’ will continue to
drive the success of our customers, shareholders, and
employees.
https://www.avient.com/sites/default/files/2023-04/Colorant Chromatics Transcend Healthcare Colorants Product Bulletin.pdf
Customized formulations for other high-performance
resins are also available.
Solutions can also be customized with functional
additives to meet other end-use product needs,
including performance enhancements such as laser
marking.
KEY CHARACTERISTICS
• Can be formulated for PESU, PPSU, and PSU
• 43 standard colors as well as custom colors
available
• Ultra-high heat resistance
• Based on raw materials pretested per ISO 10993
• Range of brilliant, vibrant colors
• Based on raw materials compliant
with food contact
• Customizable with functional additive solutions
• Based in polysulfone resins for ultra-high
performance; may be formulated for other
resin types
• Low minimum order quantities available
MARKETS AND APPLICATIONS
Transcend colorants are formulated specifically for
the healthcare market, and ideal for applications
such as:
• Dental tools and equipment
• Surgical robots
• Surgical lighting
• Diagnostic equipment
PRODUCT BULLETIN & COLOR CARD
Colors may vary from actual color shown.
https://www.avient.com/sites/default/files/2024-11/Dispersions Healthcare Leave-Behind.pdf
SILICONE ADDITIVE DISPERSIONS
General Silicone Additive Dispersions
Achieve chemical resistance, durability, and a wide range
of other enhanced physical properties to improve the
performance of silicone materials.
These dispersions are available for silicone, vinyl, and other thermoset materials
and can be customized to meet specific needs.
Dispersions Technologies for Healthcare
SPECIALTY FORMULATIONS
Aqueous Additive Dispersions
Choose dispersions or emulsions of functional additives
stabilized, suspended, and dispersed in water for use in
adhesives, bandages, and other wound care applications.
https://www.avient.com/sites/default/files/2019-12/Fermium_IR_Deck_12.16.19_for_Website.pdf
Investor Day
F E R M I U M
R E S E A R C H
M A R K E T I N G T R I P
D E C E M B E R 1 6 , 2 0 1 9
F O R W A R D L O O K I N G S T A T E M E N T S
PolyOne Corporation 2
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995.
They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other
words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales.
Loose buffer tube – made of
PBT, PTFE, Nylon 12, PP or other
polymers.
https://www.avient.com/sites/default/files/2024-12/AVNT Investor Day 2024 Presentation.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Disruptions or inefficiencies in our supply chain, logistics, or operations;
• Changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Demand for our products and services;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
• Our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA;
• Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023, under Item 1A, “Risk Factors.”
This is due to the inherent difficulty of forecasting the timing and
amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, and other non-routine costs.
Free cash flow use
2020– 2024 est.
30%
37%
6%
27%
Debt
paydown
Dividend
payments
Share
buybacks
M&A,
other
15%
CA
GR
Copyright © .
https://www.avient.com/sites/default/files/2021-12/AVNT 2021 Investor Day_0.pdf
This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, and other non-
routine costs.
Capex / Revenue
2021E (%)
Avient is Asset Light
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3
1
2
3 3
3
4
3 3
4
5
5
6
7
9
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
A
V
N
T
e
x
.